Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
- 11 December 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 16 (2), 262-278
- https://doi.org/10.1038/gt.2008.165
Abstract
Adenoviral oncolytic virotherapy represents an attractive treatment modality for central nervous system (CNS) neoplasms. However, successful application of virotherapy in clinical trials has been hampered by inadequate distribution of oncolytic vectors. Neural stem cells (NSCs) have been shown as suitable vehicles for gene delivery because they track tumor foci. In this study, we evaluated the capability of NSCs to deliver a conditionally replicating adenovirus (CRAd) to glioma. We examined NSC specificity with respect to viral transduction, migration and capacity to deliver a CRAd to tumor cells. Fluorescence-activated cell sorter (FACS) analysis of NSC shows that these cells express a variety of surface receptors that make them amenable to entry by recombinant adenoviruses. Luciferase assays with replication-deficient vectors possessing a variety of transductional modifications targeted to these receptors confirm these results. Real-time PCR analysis of the replication profiles of different CRAds in NSCs and a representative glioma cell line, U87MG, identified the CRAd-Survivin (S)-pk7 virus as optimal vector for further delivery studies. Using in vitro and in vivo migration studies, we show that NSCs infected with CRAd-S-pk7 virus migrate and preferentially deliver CRAd to U87MG glioma. These results suggest that NSCs mediate an enhanced intratumoral distribution of an oncolytic vector in malignant glioma when compared with virus injection alone.This publication has 46 references indexed in Scilit:
- Neural Progenitor Cell-mediated Delivery of Interferon Beta Improves Neuroblastoma Response to CyclophosphamideAnnals of Surgical Oncology, 2008
- Bimodal Viral Vectors andIn VivoImaging Reveal the Fate of Human Neural Stem Cells in Experimental Glioma ModelJournal of Neuroscience, 2008
- Development of neural stem cell in the adult brainCurrent Opinion in Neurobiology, 2008
- CD133 + neural stem cells in the ependyma of mammalian postnatal forebrainProceedings of the National Academy of Sciences of the United States of America, 2008
- Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-β and restricts tumor growth in a murine model of disseminated neuroblastomaJournal of Pediatric Surgery, 2007
- Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor RegressionClinical Cancer Research, 2006
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteinNature Biotechnology, 2004
- Neural Progenitor Cell Lines Inhibit Rat Tumor Growth in Vivo Cancer Research, 2004
- Intravascular Delivery of Neural Stem Cell Lines to Target Intracranial and Extracranial Tumors of Neural and Non-Neural OriginHuman Gene Therapy, 2003
- Human Neural Stem Cell Transplantation Promotes Functional Recovery in Rats With Experimental Intracerebral HemorrhageStroke, 2003